tert- and di-tert-butyl-3-hex-5-en-1-yl-3-hydroxypentandioate (30) LiHMDS ((76.3 ml, 76 .3 mmol, 1M solution in hexane) was added to 80 ml THF at -78 °C. tert-Butyl acetate (8.47 g, 72.9 mmol) was then added. After 1.5 h, methyl hept-6-enoate (4.50 g, 34.7 mmol) dissolved in 10 ml THF was added and the solution stirred at -78 °C for 1h. After the removal of the cooling bath the reaction was stirred for an additional 1.5 h. Then 100 ml 10% HCl and 50 ml Et 2 O were added and the organic phase was washed 3 times with 40 ml saturated NH 4 
S7
tert- Ester 22 (4.10 g, 18.1 mmol) was dissolved in 50 ml MeOH and the solution cooled to -30 °C. NaBH 4 (820 mg, 21.7 mmol) was added in small portions and the reaction mixture stirred for 5 h at the same temperature. After the addition of 50 ml water, the organic phase was separated and the aqueous phase extracted three times with 30 ml EA. The combined organic layers were dried over MgSO 4 , filtered and the solvent was removed under reduced pressure. After purification by column chromatography on silica (SiO 2 , PE:EA, 20:1), compound 23 (3.94 g, 17.3 mmol, 96 %) was obtained as a colorless oil. 
S8
tert- , 2856, 2360, 1726, 1463, 1361, 1255, 1102, 910, 836, 776 . (27) Alcohol 26 (1.53 g, 4.15 mmol), amide 15 (1.43 g, 5.40 mmol), PPh 3 (1.47 g, 5.60 mmol) and DEAD (880 µl, 5.60 mmol) were dissolved in 30 ml THF at 0 °C. The solution was stirred for 16 h at rt. After purification of the crude product by column S12 chromatography on silica (SiO 2 , PE:EA, 100:1), compound 27 (two diastereomers, 2.10 g, 3.41 mmol, 82 %) were obtained as yellow oils. 
N-(3-{[tert-Butyl(dimethyl)silyl]oxy}-1-[(trimethylsilyl)ethynyl]non-8-en-1-
yl)-4-methyl-N-[(5-methylfuran-2-yl)methyl]benzenesulfonamide
N-(1-Ethynyl-3-hydroxynon-8-en-1-yl)-4-methyl-N-[(5-methylfuran-2-yl)methyl]benzenesulfonamide (28)
Amide 27 (616 mg, 1.00 mmol) was dissolved in 20 ml DCM and TBAF (789 mg, 2.50 mmol) added at 0 °C. After 30 min, 30 ml saturated NH 4 Cl-solution and 20 ml EA were added and the aqueous phase was extracted three times with 20 ml EA. The combined organic layers were dried over MgSO 4 , filtered and the solvent was removed under reduced pressure. After purification by column chromatography on silica (SiO 2 , PE:EA, 10:1), 28 (540 mg, 990 µmol, 99%) was obtained as mixture of diasteromers. For pure diasteromers, additional experiments were run with diasteromerically pure starting materials. The relative configuration of 28b was assigned via X-ray crystal structure analysis. 2925, 2855, 1352, 1329, 1249, 1162, 1094, 938, 832, 773, 663 
N-(1-Ethynyl-3-hydroxynon-8-en-1-yl)-4-methyl-N-[(5-methylfuran-2-yl)methyl]benzenesulfonamide (29)
Compound 28 (534 mg, 980 µmol) was dissolved in 6 ml H 2 O/ THF (1:1) and the solution cooled to 0°C. Acetic acid (9 ml) was added and the solution stirred for 5 d at rt. After the addition of 20 ml EA, the layers were separated and the aqueous phase , 3259, 2928, 2362, 1330, 1157, 1101, 1089, 1000, 972, 937, 908, 892, 870, 816, 704, 578 . , 2924, 1711, 1640, 1598, 1345, 1307, 1161, 1094, 1051, 664 C 67.42, H 6.84, N 3.28; found C 67.25 H 7.21, N 3.03. 3 (38) For these transformations the diastereomerically pure compounds were used.
Conversion of 28a:
Compound 28a (60 mg, 110 µmol) and AuCl 3 (1.67 mg, 5.50 µmol) in 2 ml CD 3 CN were allowed to react for 30 min at rt. After evaporation of the solvent, the crude product was purified by column chromatography on silica , 2929, 2858, 2560, 2340, 1599, 1464, 1347, 1310, 1255, 1220, 1162, 1095, 1031, 933, 836, 809, 783, 664 , 3288, 3261, 3196, 3954, 3932, 2860, 2171, 1613, 1586, 1560, 1514, 1442, 1361, 1326, 1302, 1248, 1174 3-(5-Methylfuran-2-yl)-3-(prop-2-yn-1-yloxy)propan-1-ol (39)
Compound 45 (1.39 g, 4.42 mmol) was dissolved in 50 ml DCM and 10 ml H 2 O. DDQ , 2953, 2923, 2883, 1560, 1439, 1355, 1219, 1050, 1019, 963, 939, 787, 648; 1
